Pharmaceutical preparations for treatment of diseases caused by IL-6 (interleukin-6) production, namely, pharmaceutical preparations for treatment of rheumatoid arthritis; Pharmaceutical preparations comprising an anti-IL-6 (interleukin-6) receptor monoclonal antibody, namely, pharmaceutical preparations for treatment of rheumatoid arthritis and pharmaceutical preparations for prevention of rheumatoid arthritis